Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients Receiving Antiretroviral TherapyPablo Barreiro, Vincent Soriano, Eugenia Vispo et al.|The Journal of Infectious Diseases|2011Cited by 58
Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIVJ. Medraño, Vincent Soriano, Karin Neukam et al.|Clinical Infectious Diseases|2010Cited by 57
Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA loadKarin Neukam, Juan A. Pineda, Ángela Camacho et al.|Journal of Hepatology|2011Cited by 43
Life expectancy of people with HIV on antiretroviral therapy in SpainInmaculada Jarrín, Marta Rava, Jorge del Romero Raposo et al.|AIDS|2023Cited by 24
SAT-564 Management of chronic hepatitis B in people with human immunodeficiency virus infection in Europe: real-world evidence from Spain and GermanyJuan Berenguer, Jürgen Rockstroh, Pablo Ryan et al.|Journal of Hepatology|2026Cited by 0